| Literature DB >> 32895019 |
Jessica Gambardella1,2,3,4, Daniela Sorriento5, Maria Bova5, Mariarosaria Rusciano6,7, Stefania Loffredo5, Xujun Wang2,3, Angelica Petraroli5, Laura Carucci5, Ilaria Mormile5, Marco Oliveti7, Marco Bruno Morelli2,3, Antonella Fiordelisi1, Giuseppe Spadaro5, Pietro Campiglia8, Marina Sala8, Bruno Trimarco4, Guido Iaccarino1, Gaetano Santulli1,2,3,4, Michele Ciccarelli7.
Abstract
Excessive BK (bradykinin) stimulation is responsible for the exaggerated permeabilization of the endothelium in angioedema. However, the molecular mechanisms underlying these responses have not been investigated. BK receptors are Gq-protein-coupled receptors phosphorylated by GRK2 (G protein-coupled receptor kinase 2) with a hitherto unknown biological and pathophysiological significance. In the present study, we sought to identify the functional role of GRK2 in angioedema through the regulation of BK signaling. We found that the accumulation of cytosolic Ca2+ in endothelial cells induced by BK was sensitive to GRK2 activity, as it was significantly augmented by inhibiting the kinase. Accordingly, permeabilization and NO production induced by BK were enhanced, as well. In vivo, mice with reduced GRK2 levels in the endothelium (Tie2-CRE/GRK2fl+/fl-) exhibited an increased response to BK in terms of vascular permeability and extravasation. Finally, patients with reduced GRK2 levels displayed a severe phenotype of angioedema. Taken together, these findings establish GRK2 as a novel pivotal regulator of BK signaling with an essential role in the pathophysiology of vascular permeability and angioedema.Entities:
Keywords: angioedema; atherosclerosis; bradykinin; endothelium; phenotype
Mesh:
Substances:
Year: 2020 PMID: 32895019 PMCID: PMC7544666 DOI: 10.1161/HYPERTENSIONAHA.120.15130
Source DB: PubMed Journal: Hypertension ISSN: 0194-911X Impact factor: 10.190